Exact Mass: 360.0334732

Exact Mass Matches: 360.0334732

Found 45 metabolites which its exact mass value is equals to given mass value 360.0334732, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

pyruvate carbon

Tris[(2-oxopropanoyl)oxy]methyl 2-oxopropanoic acid

C13H12O12 (360.03287520000003)

TGR5 Receptor Agonist

3-(2-chlorophenyl)-N-(4-chlorophenyl)-N,5-dimethyl-1,2-oxazole-4-carboxamide

C18H14Cl2N2O2 (360.0432284)

Glucoputranjivin

(2-Methyl-1-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulphanyl}propylidene)amino sulphuric acid

C10H18NO9S2 (360.0422958)

Glucoputranjivin is a member of the class of compounds known as alkylglucosinolates. Alkylglucosinolates are organic compounds containing a glucosinolate moiety that carries an alkyl chain. Glucoputranjivin is soluble (in water) and an extremely strong acidic compound (based on its pKa). Glucoputranjivin can be found in a number of food items such as wasabi, white mustard, chinese mustard, and horseradish, which makes glucoputranjivin a potential biomarker for the consumption of these food products.

TGR5 Receptor Agonist (CCDC), a potent Takeda G protein-coupled receptor 5 (TGR5; GPCR19) agonist, shows improved potency in the U2-OS cells and melanophore cells with pEC50s of 6.8 and 7.5, respectively. TGR5 Receptor Agonist can induce peripheral and central hypersensitivity to bladder distension in mice, and increase intracellular Ca2+ concentration. TGR5 Receptor Agonist can also reduces food intake and improves insulin responsiveness, in diet-induced obese mice. TGR5 Receptor Agonist can be used to research diabetes, bladder hypersensitivity and anti-obesity[1][2][3][4].

methyl 5-iodo-2-(4-methylpiperazin-1-yl)benzoate

C13H17IN2O2 (360.0334732)

3-iodo-4-[(4-methylpiperazin-1-yl)methyl]benzoic acid

C13H17IN2O2 (360.0334732)

4-(4-ethylpiperazin-1-yl)-3-iodobenzoic acid

C13H17IN2O2 (360.0334732)

(2E,5E)-2-((2-chlorophenyl)imino)-5-(4-hydroxy-3-methoxybenzylidene)thiazolidin-4-one

C17H13ClN2O3S (360.0335378000001)

O-[2-(1,3-Dioxo-1,3-Dihydro-2h-Isoindol-2-Yl)ethyl] (4-Chlorophenyl)thiocarbamate

C17H13ClN2O3S (360.0335378000001)

Glucoputranjivin(1-)

C10H18NO9S2- (360.0422958)

Isopropylglucosinolate

C10H18NO9S2- (360.0422958)

(E)-2-cyano-N-(2,4-dichlorophenyl)-3-[5-(2-methylcyclopropyl)furan-2-yl]prop-2-enamide

C18H14Cl2N2O2 (360.0432284)

2-(ethylthio)-4-{[5-(2-nitrophenyl)-2-furyl]methylene}-1,3-thiazol-5(4H)-one

C16H12N2O4S2 (360.0238472)

N-[(E)-[5-(2-chlorophenyl)furan-2-yl]methylideneamino]benzenesulfonamide

C17H13ClN2O3S (360.0335378000001)

(2R)-2-(4-{[3-chloro-5-(trifluoromethyl)pyridin-2-yl]oxy}phenoxy)propanoate

C15H10ClF3NO4- (360.02504260000006)

N-(3-bromophenyl)-6,7-dimethoxyquinazolin-4-aminium

C16H15BrN3O2+ (360.034757)

1-S-[(1Z)-N-(sulfonatooxy)butanimidoyl]-1-thio-beta-D-glucopyranose

C10H18NO9S2- (360.0422958)

(2S)-2-(4-{[3-chloro-5-(trifluoromethyl)pyridin-2-yl]oxy}phenoxy)propanoate

C15H10ClF3NO4- (360.02504260000006)

2-cyano-N-(2,4-dichlorophenyl)-3-[5-(2-methylcyclopropyl)-2-furanyl]-2-propenamide

C18H14Cl2N2O2 (360.0432284)

propylglucosinolate

C10H18NO9S2 (360.0422958)

An alkylglucosinolate that is the conjugate base of propylglucosinolic acid.

Glucoputranjivin(1-)

C10H18NO9S2 (360.0422958)

A alkylglucosinolate that is the conjugate base of glucoputranjivin.

FX-909

C17H10F2N2O3S (360.03801740000006)

FX-909 is a covalent peroxisome proliferator-activated receptor gamma (PPARG) inverse agonist. FX-909 can be used for the research of cancer[1].

SSR180711 (hydrochloride)

C14H18BrClN2O2 (360.0240098)

SSR180711 hydrochloride is an orally active, selective and reversible α7 acetylcholine nicotinic receptor (n-AChRs) partial agonist. SSR180711 hydrochloride can act on rat α7 n-AChR (Ki=22 nM; IC50=30 nM) and human α7 n-AChR (Ki=14 nM; IC50=18 nM). SSR180711 hydrochloride increases glutamatergic neurotransmission, ACh release and long-term potentiation (LTP) in the hippocampus[1].